Trademarkia Logo

Australia

AU$
Trademark Search
ANDEXXA

View On IPO.GOV.AU

ANDEXXA
Protected: Registered/protected

Last updated on 24 Apr 2025

Owner Info

Alexion Pharmaceuticals, Inc.

121 Seaport Boulevard

Boston MA 02210, UNITED STATES OF AMERICA

Serial Number

1777272 filed on 17 Mar 2016

Correspondent

Dennemeyer & Associates S.A.

55, rue des Bruyères,

L-1274 HOWALD,

LUXEMBOURG

ANDEXXA

Classification Information

Class [005]
Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, he Read More

Mark Details

Serial Number

1777272

Registered On

17 Mar 2016

Renewal On

7 Oct 2035

Mark Type

WORD

Priority Claim (Convention Details)

Date

2 Oct 2015

Mark Type

US

Legal History

Show more

Status DateAction Taken
24th Apr 2025Renewal Requested
7th Oct 2023Full Assignment - Subsequent Owner Registered Published
5th Oct 2023Full Assignment Requested
15th Dec 2022Amendment to Amend Owner Requested
18th Nov 2021Amendment to Amend Owner Requested
16th Apr 2020Amendment to International Registration Contact Requested
14th May 2019International Registration in Australia Protected After Adverse (No amendments) correspondence sent
14th May 2019International Registration in Australia Protected After Adverse (No amendments) correspondence sent
14th May 2019IP Right Registration Published
14th May 2019Status change to Registered/Protected